View Older Stories

Feb 3, 2026 06:35AM WAVE Life Sciences (WVE) PT Raised to $43 at Canaccord Genuity

Feb 2, 2026 01:16PM Raymond James: 'WVE regains full economic rights to WVE-006 from GSK'

Feb 2, 2026 12:26PM WAVE Life Sciences (WVE) PT Raised to $50 at Clear Street

Feb 2, 2026 07:30AM Wave regains full control of WVE-006 drug from GSK partnership

Jan 12, 2026 07:33AM Wave Life Sciences outlines 2026 priorities for obesity drug development

Jan 7, 2026 04:54AM WAVE Life Sciences (WVE) PT Raised to $26 at Raymond James

Jan 6, 2026 01:41PM Clear Street Reiterates Buy Rating on WAVE Life Sciences (WVE)

Jan 6, 2026 11:03AM WAVE Life Sciences (WVE) call put ratio 2.7 calls to 1 put with a focus on January 19 calls as share price up 17%

Dec 16, 2025 06:07AM WAVE Life Sciences (WVE) PT Raised to $32 at Oppenheimer

Dec 15, 2025 06:18AM WAVE Life Sciences (WVE) PT Raised to $50 at Truist Securities

Dec 12, 2025 06:44AM WAVE Life Sciences (WVE) PT Raised to $33 at Wedbush, Added to BIL

Dec 12, 2025 03:38AM Jefferies Reiterates Buy Rating on WAVE Life Sciences (WVE)

Dec 11, 2025 11:46AM WAVE Life Sciences (WVE) PT Raised to $37 at B.Riley

Dec 9, 2025 06:21AM WAVE Life Sciences (WVE) PT Raised to $40 at Canaccord Genuity

Dec 9, 2025 06:17AM WAVE Life Sciences (WVE) PT Raised to $30 at Citi

Dec 9, 2025 05:27AM Increasing unusual call option volume: WVE WRBY CRH PLAB AMLP AM CNM ELAN GPCR

Dec 9, 2025 04:13AM WAVE Life Sciences (WVE) PT Raised to $21 at Raymond James

Dec 9, 2025 12:53AM RBC Capital Upgrades WAVE Life Sciences (WVE) to Outperform

Dec 8, 2025 04:57PM After-hours movers: NVIDIA, Toll Brothers, and more

Dec 8, 2025 02:15PM WAVE Life Sciences (WVE) PT Raised to $21 at Raymond James

Dec 8, 2025 01:20PM WAVE Life Sciences (WVE) PT Raised to $28 at Leerink Partners

Nov 10, 2025 04:04PM WAVE Life Sciences (WVE) PT Raised to $20 at Wedbush

Nov 3, 2025 10:00AM Truist: 'QURE Update Minimal Read-Through To PTCT & WVE, In Our View'

Oct 29, 2025 04:53PM Wave Life Sciences reports positive obesity trial results

Oct 27, 2025 07:17AM WAVE Life Sciences (WVE) Can Show Fat Mass Loss- Cantor Fitzgerald

Oct 14, 2025 04:23PM Clear Street Starts WAVE Life Sciences (WVE) at Buy, PT $22

Sep 3, 2025 08:40PM WAVE Life Sciences (WVE) PT Lowered to $16 at Jones Trading

Sep 3, 2025 01:18PM Raymond James on WAVE Life Sciences (WVE): 'We continue to view WVE’s wholly-owned gene-editing programs as more likely LT value drivers'

Sep 3, 2025 01:09PM WAVE Life Sciences (WVE) PT Raised to $26 at Leerink Partners

Sep 3, 2025 07:30AM Wave Life Sciences reports positive data from AATD drug trial

Aug 20, 2025 06:46AM Canaccord Genuity Reiterates Buy Rating on WAVE Life Sciences (WVE)

Aug 4, 2025 08:33AM Canaccord Genuity Starts WAVE Life Sciences (WVE) at Buy, 'making big waves in the RNA space'

Jul 30, 2025 07:54AM WAVE Life Sciences (WVE) Misses Q2 EPS by 4c

Jul 28, 2025 01:58AM Oppenheimer Starts WAVE Life Sciences (WVE) at Outperform

Jul 16, 2025 05:50AM Citi Starts WAVE Life Sciences (WVE) at Buy

Jul 11, 2025 07:01AM Cantor Fitzgerald Reiterates Overweight Rating on WAVE Life Sciences (WVE)

Jun 23, 2025 07:11AM Cantor Fitzgerald Reiterates Overweight Rating on WAVE Life Sciences (WVE)

Jun 23, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)

Jun 20, 2025 04:02PM Wave Life Sciences (WVE) Announces Oral Presentation of Preclinical Data Supporting WVE-007

Jun 17, 2025 02:48PM WAVE Life Sciences (WVE) 1100 contracts of January 10 calls trade as share price down 2.4%

May 28, 2025 08:01AM WAVE Life Sciences (WVE) Appoints Christopher Wright as Chief Medical Officer

May 12, 2025 06:59AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)

May 8, 2025 07:45AM WAVE Life Sciences (WVE) Misses Q1 EPS by 4c

Apr 29, 2025 06:34AM Cantor Fitzgerald Starts WAVE Life Sciences (WVE) at Overweight

Apr 8, 2025 08:00AM Wedbush Starts WAVE Life Sciences (WVE) at Outperform

Mar 27, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)

Mar 26, 2025 09:43AM Jefferies Reiterates Buy Rating on WAVE Life Sciences (WVE)

Mar 26, 2025 07:31AM WAVE Life Sciences (WVE) Announces Positive Data from FORWARD-53 Clinical Trial in DMD

Mar 10, 2025 03:25PM Jones Trading Reiterates Buy Rating on WAVE Life Sciences (WVE)

Mar 10, 2025 12:58PM Mizuho Reiterates Outperform Rating on WAVE Life Sciences (WVE)

View Older Stories